ResearcherNational Cancer Centre JapanActive in the last 2 years
Takeshi Takamoto
Matched on ORCID iD 0000-0003-0455-6412; OpenAlex author ID A5014166430, A5087217398. Sources: OpenAlex.
Their work
- Papers
- 8
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2022: 2 papers · 2023: none · 2024: 3 papers · 2025: 1 paper · 2026: 2 papers
Papers 8
- Optimizing surgical indication in patients with borderline resectable pancreatic ductal adenocarcinoma to prevent futile pancreatectomy. Co-author DOI 10.1016/j.hpb.2025.12.021↗
- Large Resectable Pancreatic Cancer is Associated with Futile Surgery: A Resectable But Not Curable Disease? Co-author DOI 10.1245/s10434-025-18511-2↗
- Neoadjuvant gemcitabine and S-1 in pancreatic ductal adenocarcinoma: Effects on nutritional status and pancreaticoduodenectomy outcomes. Co-author DOI 10.1016/j.surg.2024.109026↗
- Oligo-like liver metastasis: A novel prognostic indicator to improve survival in pancreatic cancer. Co-author DOI 10.1002/ags3.12753↗
- Safety and feasibility of percutaneous abdominal lavage cytology screening (PACS) prior to surgical resection for pancreatic cancer. Co-author DOI 10.1007/s00261-024-04510-6↗
- [A case of R0 resection in conversion surgery after duodenal stent placement for locally advanced unresectable pancreatic cancer with duodenal stenosis]. Co-author DOI 10.11405/nisshoshi.121.407↗
- Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail. Co-author DOI 10.1245/s10434-022-11950-1↗
- ASO Author Reflections: Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail. Co-author DOI 10.1245/s10434-022-11957-8↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Satoshi Nara · 5 shared papers, 2022–2025 · strength 1.02
- Paper Neoadjuvant gemcitabine and S-1 in pancreatic ductal adenocarcinoma: Effects on nutritional status and pancreaticoduode… DOI 10.1016/j.surg.2024.109026↗
- Paper Oligo-like liver metastasis: A novel prognostic indicator to improve survival in pancreatic cancer. DOI 10.1002/ags3.12753↗
- Paper Safety and feasibility of percutaneous abdominal lavage cytology screening (PACS) prior to surgical resection for pancr… DOI 10.1007/s00261-024-04510-6↗
- Daisuke Ban · 5 shared papers, 2022–2025 · strength 1.02
- Paper Neoadjuvant gemcitabine and S-1 in pancreatic ductal adenocarcinoma: Effects on nutritional status and pancreaticoduode… DOI 10.1016/j.surg.2024.109026↗
- Paper Oligo-like liver metastasis: A novel prognostic indicator to improve survival in pancreatic cancer. DOI 10.1002/ags3.12753↗
- Paper Safety and feasibility of percutaneous abdominal lavage cytology screening (PACS) prior to surgical resection for pancr… DOI 10.1007/s00261-024-04510-6↗
- Minoru Esaki · 5 shared papers, 2022–2025 · strength 1.02
- Paper Neoadjuvant gemcitabine and S-1 in pancreatic ductal adenocarcinoma: Effects on nutritional status and pancreaticoduode… DOI 10.1016/j.surg.2024.109026↗
- Paper Oligo-like liver metastasis: A novel prognostic indicator to improve survival in pancreatic cancer. DOI 10.1002/ags3.12753↗
- Paper Safety and feasibility of percutaneous abdominal lavage cytology screening (PACS) prior to surgical resection for pancr… DOI 10.1007/s00261-024-04510-6↗
- Sho Kiritani · 2 shared papers, 2026 · strength 0.55
- Paper Large Resectable Pancreatic Cancer is Associated with Futile Surgery: A Resectable But Not Curable Disease? DOI 10.1245/s10434-025-18511-2↗
- Paper Optimizing surgical indication in patients with borderline resectable pancreatic ductal adenocarcinoma to prevent futil… DOI 10.1016/j.hpb.2025.12.021↗
- Yusuke Kazami · 2 shared papers, 2026 · strength 0.55
- Paper Large Resectable Pancreatic Cancer is Associated with Futile Surgery: A Resectable But Not Curable Disease? DOI 10.1245/s10434-025-18511-2↗
- Paper Optimizing surgical indication in patients with borderline resectable pancreatic ductal adenocarcinoma to prevent futil… DOI 10.1016/j.hpb.2025.12.021↗
- Satoru Abe · 2 shared papers, 2026 · strength 0.55
- Paper Large Resectable Pancreatic Cancer is Associated with Futile Surgery: A Resectable But Not Curable Disease? DOI 10.1245/s10434-025-18511-2↗
- Paper Optimizing surgical indication in patients with borderline resectable pancreatic ductal adenocarcinoma to prevent futil… DOI 10.1016/j.hpb.2025.12.021↗
- Kiyoshi Hasegawa · 2 shared papers, 2026 · strength 0.55
- Paper Large Resectable Pancreatic Cancer is Associated with Futile Surgery: A Resectable But Not Curable Disease? DOI 10.1245/s10434-025-18511-2↗
- Paper Optimizing surgical indication in patients with borderline resectable pancreatic ductal adenocarcinoma to prevent futil… DOI 10.1016/j.hpb.2025.12.021↗
- Kazuaki Shimada · 3 shared papers, 2022–2024 · strength 0.54
- Paper Oligo-like liver metastasis: A novel prognostic indicator to improve survival in pancreatic cancer. DOI 10.1002/ags3.12753↗
- Paper Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail. DOI 10.1245/s10434-022-11950-1↗
- Paper ASO Author Reflections: Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinom… DOI 10.1245/s10434-022-11957-8↗
- Shunsuke Sugawara · 3 shared papers, 2022–2024 · strength 0.48
- Paper Safety and feasibility of percutaneous abdominal lavage cytology screening (PACS) prior to surgical resection for pancr… DOI 10.1007/s00261-024-04510-6↗
- Paper Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail. DOI 10.1245/s10434-022-11950-1↗
- Paper ASO Author Reflections: Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinom… DOI 10.1245/s10434-022-11957-8↗
- Kei Kitamura · 2 shared papers, 2022 · strength 0.30
- Paper Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail. DOI 10.1245/s10434-022-11950-1↗
- Paper ASO Author Reflections: Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinom… DOI 10.1245/s10434-022-11957-8↗
- Nobuyoshi Hiraoka · 2 shared papers, 2022 · strength 0.30
- Paper Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail. DOI 10.1245/s10434-022-11950-1↗
- Paper ASO Author Reflections: Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinom… DOI 10.1245/s10434-022-11957-8↗
- Kazunaga Ishigaki · 1 shared paper, 2026 · strength 0.26
- Naminatsu Takahara · 1 shared paper, 2026 · strength 0.26
- Tatsunori Suzuki · 1 shared paper, 2026 · strength 0.26
- Mitsuhiro Fujishiro · 1 shared paper, 2026 · strength 0.26
- Ryo Saito · 1 shared paper, 2024 · strength 0.24
- Hirokazu Komatsu · 1 shared paper, 2024 · strength 0.21
- Yuta Iwai · 1 shared paper, 2024 · strength 0.21
- Mizuki Ozawa · 1 shared paper, 2024 · strength 0.18
- Ryosuke Umino · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.